TY - JOUR
T1 - 5-HT1A receptor full agonist, 8-OH-DPAT, exerts antidepressant-like effects in the forced swim test in ACTH-treated rats
AU - Kitamura, Yoshihisa
AU - Araki, Hiroaki
AU - Shibata, Kazuhiko
AU - Gomita, Yutaka
AU - Tanizaki, Yoshiro
PY - 2003/11/14
Y1 - 2003/11/14
N2 - We examined the effect of adrenocorticotropic hormone (ACTH) on the immobilization of rats in the forced swim test after administration of the 5-HT1A receptor agonist, 8-hydroxy-2-di-n-propylamino tetralin (8-OH-DPAT). Imipramine (3-30 mg/kg, i.p.) or 8-OH-DPAT (0.1-1 mg/kg, s.c.) significantly decreased the duration of immobility in normal rats. The immobility-decreasing effect of imipramine was blocked when ACTH was administered for 14 days. On the other hand, the immobility-decreasing effect induced by 8-OH-DPAT was not blocked by chronic administration of ACTH for 14 days. These findings indicate that 8-OH-DPAT can be useful in an animal model of depressive conditions resistant to antidepressant treatment.
AB - We examined the effect of adrenocorticotropic hormone (ACTH) on the immobilization of rats in the forced swim test after administration of the 5-HT1A receptor agonist, 8-hydroxy-2-di-n-propylamino tetralin (8-OH-DPAT). Imipramine (3-30 mg/kg, i.p.) or 8-OH-DPAT (0.1-1 mg/kg, s.c.) significantly decreased the duration of immobility in normal rats. The immobility-decreasing effect of imipramine was blocked when ACTH was administered for 14 days. On the other hand, the immobility-decreasing effect induced by 8-OH-DPAT was not blocked by chronic administration of ACTH for 14 days. These findings indicate that 8-OH-DPAT can be useful in an animal model of depressive conditions resistant to antidepressant treatment.
KW - 5-HT receptor
KW - 8-OH-DPAT (8-hydroxy-2-di-n-propylamino tetralin)
KW - Depression treatment-resistant
KW - Forced swim test
KW - Imipramine
UR - http://www.scopus.com/inward/record.url?scp=0344153885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344153885&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2003.09.008
DO - 10.1016/j.ejphar.2003.09.008
M3 - Article
C2 - 14637177
AN - SCOPUS:0344153885
SN - 0014-2999
VL - 481
SP - 75
EP - 77
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -